Literature DB >> 9774124

Differing outcomes of gram-positive and gram-negative peritonitis.

L Troidle1, N Gorban-Brennan, A Kliger, F Finkelstein.   

Abstract

Peritonitis remains the leading cause of patient dropout from continuous peritoneal dialysis (CPD) therapy. Few studies have compared patient morbidity, mortality, and outcome for patients undergoing CPD who develop gram-positive and gram-negative peritonitis. We retrospectively reviewed the charts of patients who developed either gram-positive or gram-negative peritonitis between January 1, 1993, and December 31, 1995. Three hundred seventy-five patients who developed 415 episodes of gram-positive and gram-negative peritonitis were maintained on CPD therapy during this time period. There was no difference in age, race, and sex between patients who developed gram-positive or gram-negative peritonitis. More patients with diabetes developed gram-negative peritonitis than gram-positive peritonitis (53% v 40%, respectively; P < 0.05). Coagulase-negative staphylococcal species accounted for 47% of all gram-positive episodes, whereas Klebsiella organisms, Escherichia coli, and Enterobacter organisms accounted for 63% of all gram-negative episodes. Significantly more patients who developed gram-positive peritonitis continued CPD therapy 2 weeks and 6 months after the onset of peritonitis than patients who developed gram-negative peritonitis (97% v 73%; P < 0.05 at 2 weeks and 81% v 58% at 6 months; P < 0.05, respectively). Nine percent of the patients who developed gram-positive peritonitis died within 6 months after the onset of peritonitis, whereas 21% of the patients who developed gram-negative peritonitis died (P < 0.05). Patients who developed gram-negative peritonitis were significantly more likely to require hospitalization than patients who developed gram-positive peritonitis (74% v 24%; P < 0.001). More patients with gram-negative peritonitis required peritoneal catheter removal than patients with gram-positive peritonitis (18% v 4%; P < 0.001). Thirty-two percent of the patients who developed gram-positive peritonitis re-developed an episode of peritonitis with the same organism compared with only 9% of the patients who developed gram-negative peritonitis. Furthermore, peritonitis recurrence with the same organism within 6 months after the initial episode was noted in 60% of the patients with peritonitis caused by Staphylococcus aureus compared with 24% of patients with peritonitis caused by other gram-positive organisms (P < 0.05). We conclude that the outcomes of gram-positive and gram-negative peritonitis are different. When rates of peritonitis are used to predict outcome, it appears that gram-positive and gram-negative peritonitis rates need to be examined separately.

Entities:  

Mesh:

Year:  1998        PMID: 9774124     DOI: 10.1016/s0272-6386(98)70026-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  29 in total

1.  Factors Associated With Increased Hospital Length of Stay in Peritoneal Dialysis Patients With Peritonitis: A Need for Antimicrobial Stewardship?

Authors:  Taylor Morrisette; Robert B Canada; Danielle Padgett; Joanna Q Hudson
Journal:  Hosp Pharm       Date:  2018-12-07

Review 2.  Infectious complications in dialysis--epidemiology and outcomes.

Authors:  Philip Kam-Tao Li; Kai Ming Chow
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

3.  Benefit of an operating vehicle preventing peritonitis in peritoneal dialysis patients: a retrospective, case-controlled study.

Authors:  Pan Fang; Jia Lu; Ying-Hong Liu; Hong-Mei Deng; Lei Zhang; Hong-Qing Zhang
Journal:  Int Urol Nephrol       Date:  2018-03-05       Impact factor: 2.370

4.  32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.

Authors:  Sadie van Esch; Raymond T Krediet; Dirk G Struijk
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

5.  Microbiology and outcomes of peritonitis in northern India.

Authors:  Kashi Nath Prasad; Kamini Singh; Arshi Rizwan; Priyanka Mishra; Dinesh Tiwari; Narayan Prasad; Amit Gupta
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

6.  Roles of neutrophil gelatinase-associated lipocalin in continuous ambulatory peritoneal dialysis-related peritonitis.

Authors:  Joseph C K Leung; Man Fai Lam; Sydney C W Tang; Loretta Y Y Chan; K Y Tam; Terence P S Yip; Kar Neng Lai
Journal:  J Clin Immunol       Date:  2009-01-16       Impact factor: 8.317

7.  The role of virulence factors in the outcome of staphylococcal peritonitis in CAPD patients.

Authors:  Pasqual Barretti; Augusto C Montelli; Jackson E N Batalha; Jacqueline C T Caramori; Maria de Lourdes R S Cunha
Journal:  BMC Infect Dis       Date:  2009-12-22       Impact factor: 3.090

8.  The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.

Authors:  Lei Zhang; Sunil V Badve; Elaine M Pascoe; Elaine Beller; Alan Cass; Carolyn Clark; Janak de Zoysa; Nicole M Isbel; Steven McTaggart; Alicia T Morrish; E Geoffrey Playford; Anish Scaria; Paul Snelling; Liza A Vergara; Carmel M Hawley; David W Johnson
Journal:  Perit Dial Int       Date:  2015-07-29       Impact factor: 1.756

9.  Effect of gastric acid suppressants and prokinetics on peritoneal dialysis-related peritonitis.

Authors:  Ji Eun Kwon; Seong-Joon Koh; Jaeyoung Chun; Ji Won Kim; Byeong Gwan Kim; Kook Lae Lee; Jong Pil Im; Joo Sung Kim; Hyun Chae Jung
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

10.  Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases.

Authors:  Cheuk-Chun Szeto; Bonnie Ching-Ha Kwan; Kai-Ming Chow; Miu-Fong Lau; Man-Ching Law; Kwok-Yi Chung; Chi-Bon Leung; Philip Kam-Tao Li
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-21       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.